Nevertheless, it is crucial to discuss possible underlying mechanisms linking TLR4 to BP regulation in the current literature, especially with the promising, but challenging, opportunity to target TLR4 or its downstream signaling adaptors (MyD88 or TRIF) to manage vascular pathologies such as hypertension. This evidence concerns the gene TLR4 and Hypertension.